Kathryn E Oliver

9PUBLICATIONS
22CO-AUTHORS
CybercrimeInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Profiling the CFTR Variant Selectivity and Off-Target Interactions of VX-121.

|Oct 24, 2025
Evaluating Georgia's Cystic Fibrosis Newborn Screening Algorithm to Inform Improvement Recommendations.

Brittany Truitt, Eileen Barr, Angela Wittenauer

|Oct 24, 2025
CFTR Variant Frequencies and Newborn Screening Panel Performance in the Diverse CF Population Receiving Care in the State of Georgia.

Eileen Barr, Brittany Truitt, Andrew Jergel

|Sep 18, 2025
General Trends in the Calnexin-Dependent Expression and Pharmacological Rescue of Clinical CFTR Variants.

Austin Tedman, John A Olson, Minsoo Kim

|Apr 09, 2025
Recent developments in cystic fibrosis drug discovery: where are we today?

Miquéias Lopes-Pacheco, Ashlyn G Winters, JaNise J Jackson

|Jan 25, 2024
Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.

Eli Fritz McDonald, Kathryn E Oliver, Jonathan P Schlebach

Pageof 2